Literature DB >> 11082801

The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers.

M E Wewers1, J L Neidig, K E Kihm.   

Abstract

The purpose of this pilot study was to examine the effectiveness of an 8-week, nurse-managed, peer-led smoking cessation intervention among HIV-positive smokers. The intervention was based on the Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline and was delivered by an ex-smoker who was HIV positive and had been trained by an advanced practice nurse to deliver cessation counseling. Eight male HIV-positive smokers were assigned to the intervention group and received (a) 21 mg nicotine patch therapy for 6 weeks, (b) weekly face-to-face or telephone counseling, and (c) skills training that included substitute strategies for dealing with not smoking. Those participants assigned to the control group received written self-help materials for smoking cessation. Abstinence rates at end of intervention and 8 months were compared between groups. At end of treatment, 62.5% of intervention group participants were biochemically confirmed as abstinent from smoking compared with 0% in the control group. Eight-month abstinence rates were 50% among the intervention group compared with 0% in the control group.

Entities:  

Mesh:

Year:  2000        PMID: 11082801     DOI: 10.1016/S1055-3290(06)60353-1

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  30 in total

Review 1.  Lung cancer in HIV Infection.

Authors:  Deepthi Mani; Missak Haigentz; David M Aboulafia
Journal:  Clin Lung Cancer       Date:  2011-07-29       Impact factor: 4.785

2.  Screening for Chronic Obstructive Pulmonary Disease (COPD) in an Urban HIV Clinic: A Pilot Study.

Authors:  Daniel K Shirley; Robert J Kaner; Marshall J Glesby
Journal:  AIDS Patient Care STDS       Date:  2015-02-27       Impact factor: 5.078

3.  Pilot evaluation of a brief intervention to improve nicotine patch adherence among smokers living with HIV/AIDS.

Authors:  Joan S Tucker; William G Shadel; Frank H Galvan; Diana Naranjo; Christian Lopez; Claude Setodji
Journal:  Psychol Addict Behav       Date:  2016-10-13

4.  A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers.

Authors:  Alyson B Moadel; Steven L Bernstein; Robin J Mermelstein; Julia H Arnsten; Eileen H Dolce; Jonathan Shuter
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

Review 5.  Smoking Cessation for People Living With HIV/AIDS: A Literature Review and Synthesis.

Authors:  David M Ledgerwood; Russell Yskes
Journal:  Nicotine Tob Res       Date:  2016-05-31       Impact factor: 4.244

6.  Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum.

Authors:  Monica S Webb; Peter A Vanable; Michael P Carey; Donald C Blair
Journal:  J Behav Med       Date:  2007-06-15

7.  Prevention for substance-using HIV-positive young people: telephone and in-person delivery.

Authors:  Mary Jane Rotheram-Borus; Dallas Swendeman; W Scott Comulada; Robert E Weiss; Martha Lee; Marguerita Lightfoot
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

8.  Motivation and patch treatment for HIV+ smokers: a randomized controlled trial.

Authors:  Elizabeth E Lloyd-Richardson; Cassandra A Stanton; George D Papandonatos; William G Shadel; Michael Stein; Karen Tashima; Timothy Flanigan; Kathleen Morrow; Charles Neighbors; Raymond Niaura
Journal:  Addiction       Date:  2009-08-28       Impact factor: 6.526

Review 9.  Human immunodeficiency virus-associated obstructive lung diseases.

Authors:  Matthew R Gingo; Alison Morris; Kristina Crothers
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

10.  Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS.

Authors:  Ellen R Gritz; Heather E Danysh; Faith E Fletcher; Irene Tami-Maury; Michelle Cororve Fingeret; Rachel Marks King; Roberto C Arduino; Damon J Vidrine
Journal:  Clin Infect Dis       Date:  2013-05-23       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.